Invention Grant
- Patent Title: Use of the GK-1 peptide as an antitumoral and/or antimetastatic agent
-
Application No.: US16302786Application Date: 2017-05-18
-
Publication No.: US11020449B2Publication Date: 2021-06-01
- Inventor: Edda Lydia Sciutto Conde , Gladis del Carmen Fragoso Gonzalez , Diana Torres Garcia , Jacquelynne Brenda Cervantes Torres , Rene Alvaro Segura Velazquez , Armando Perez Torres , Karen Manucharyan
- Applicant: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
- Applicant Address: MX Mexico City
- Assignee: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
- Current Assignee: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
- Current Assignee Address: MX Mexico City
- Agency: Shumaker, Loop & Kendrick, LLP
- Priority: MXMX/a/2016/006460 20160518
- International Application: PCT/MX2017/000055 WO 20170518
- International Announcement: WO2017/200369 WO 20171123
- Main IPC: A61K38/10
- IPC: A61K38/10 ; A61P35/00
Abstract:
The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
Public/Granted literature
- US20200222495A1 USE OF THE GK-1 PEPTIDE AS AN ANTITUMORAL AND/OR ANTIMETASTATIC AGENT Public/Granted day:2020-07-16
Information query
IPC分类:
